1. Genetic-hormonal pathways to non-squamous lung cancer: prognosticator and a therapeutic target
   Mustafa A. Jaber, 2023, American Journal of BioMedicine CrossRef
2. Cytoplasmic expression of estrogen receptor β may predict poor outcome of EGFR‑TKI therapy in metastatic lung adenocarcinoma
   Xiaosheng Ding et al, 2018, Oncology Letters CrossRef
3. Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer
   Robert Hsu et al, 2023, Frontiers in Oncology CrossRef
4. An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis and Lung Cancer Treatment
   Vianey Rodriguez-Lara et al, 2021, Frontiers in Medicine CrossRef
5. Hormonal factors in association with lung cancer among Asian women: A pooled analysis from the International Lung Cancer Consortium
   Kexin Jin et al, 2021, International Journal of Cancer CrossRef
6. Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
   Sze‐Ching Wong et al, 2023, Molecular Oncology CrossRef
7. Estrogen, Estrogen Receptor and Lung Cancer
   Li-Han Hsu et al, 2017, International Journal of Molecular Sciences CrossRef
8. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer
   Edward B. Garon et al, 2018, Lung Cancer CrossRef
9. The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study
   Chia-Chen Wu et al, 2023, Menopause CrossRef
10. Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective
    Radhashree Maitra et al, 2021, Cancers CrossRef